AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
Latest, Q2 2026
80
Period ended Jun 30, 2026
Change on a year earlier
+17.6%
68 in Q2 2025
History
10 quarters
Since Q2 2017
Sources
9
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Finance income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 80 | +17.6% | Form 6-K (filed 2026-07-27) ↗ |
| Q2 2025 | Jun 30, 2025 | 68 | -32.0% | Form 6-K (filed 2025-07-29) ↗ |
| Q2 2024 | Jun 30, 2024 | 100 | +56.3% | Form 6-K (filed 2024-07-25) ↗ |
| Q2 2023 | Jun 30, 2023 | 64 | +255.6% | Form 6-K (filed 2023-07-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 18 | +157.1% | Form 6-K (filed 2022-07-29) ↗ |
| Q2 2021 | Jun 30, 2021 | 7 | -68.2% | Form 6-K (filed 2021-07-30) ↗ |
| Q2 2020 | Jun 30, 2020 | 22 | -46.3% | Form 6-K/A (filed 2020-07-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 41 | -4.7% | Form 6-K (filed 2019-07-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 43 | +53.6% | Form 6-K (filed 2018-07-26) ↗ |
| Q2 2017 | Jun 30, 2017 | 28 | – | Form 6-K (filed 2018-07-26) ↗ |
Cite this data
StockData. (2026). AstraZeneca Finance income ($M) ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_int_inc
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.